Caitlin Cronin
Stock Analyst at Canaccord Genuity
(3.63)
# 780
Out of 5,154 analysts
48
Total ratings
41.67%
Success rate
11.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $34 → $35 | $34.31 | +2.01% | 5 | Mar 5, 2026 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $85 → $90 | $70.41 | +27.82% | 4 | Feb 26, 2026 | |
| GMED Globus Medical | Maintains: Buy | $105 → $112 | $87.10 | +28.59% | 3 | Jan 9, 2026 | |
| ENOV Enovis | Maintains: Buy | $58 → $50 | $24.51 | +104.00% | 4 | Dec 17, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $13.23 | +13.38% | 6 | Dec 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $27 → $37 | $28.55 | +29.60% | 8 | Dec 5, 2025 | |
| TELA TELA Bio | Maintains: Buy | $7 → $4 | $0.90 | +346.13% | 5 | Nov 18, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $25 | $12.23 | +104.42% | 5 | Oct 31, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $58 | $33.71 | +72.06% | 4 | Aug 1, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $8.41 | +78.36% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $4.54 | -11.89% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $130 | $94.11 | +38.14% | 1 | Feb 23, 2024 |
Smith & Nephew
Mar 5, 2026
Maintains: Hold
Price Target: $34 → $35
Current: $34.31
Upside: +2.01%
Establishment Labs Holdings
Feb 26, 2026
Maintains: Buy
Price Target: $85 → $90
Current: $70.41
Upside: +27.82%
Globus Medical
Jan 9, 2026
Maintains: Buy
Price Target: $105 → $112
Current: $87.10
Upside: +28.59%
Enovis
Dec 17, 2025
Maintains: Buy
Price Target: $58 → $50
Current: $24.51
Upside: +104.00%
InMode
Dec 17, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $13.23
Upside: +13.38%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $27 → $37
Current: $28.55
Upside: +29.60%
TELA Bio
Nov 18, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $0.90
Upside: +346.13%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $25
Current: $12.23
Upside: +104.42%
Vericel
Aug 1, 2025
Maintains: Buy
Price Target: $61 → $58
Current: $33.71
Upside: +72.06%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $8.41
Upside: +78.36%
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $4.54
Upside: -11.89%
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $94.11
Upside: +38.14%